AR049577A1 - Derivados de hidantoina, procesos para su preparacion, composiciones y su uso - Google Patents
Derivados de hidantoina, procesos para su preparacion, composiciones y su usoInfo
- Publication number
- AR049577A1 AR049577A1 ARP050102792A ARP050102792A AR049577A1 AR 049577 A1 AR049577 A1 AR 049577A1 AR P050102792 A ARP050102792 A AR P050102792A AR P050102792 A ARP050102792 A AR P050102792A AR 049577 A1 AR049577 A1 AR 049577A1
- Authority
- AR
- Argentina
- Prior art keywords
- processes
- preparation
- hydantoin derivatives
- compositions
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0401763A SE0401763D0 (sv) | 2004-07-05 | 2004-07-05 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
AR049577A1 true AR049577A1 (es) | 2006-08-16 |
Family
ID=32768774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050102792A AR049577A1 (es) | 2004-07-05 | 2005-07-05 | Derivados de hidantoina, procesos para su preparacion, composiciones y su uso |
Country Status (18)
Country | Link |
---|---|
US (1) | US20080004317A1 (sv) |
EP (1) | EP1794147A1 (sv) |
JP (1) | JP2008505172A (sv) |
KR (1) | KR20070038498A (sv) |
CN (1) | CN1980915A (sv) |
AR (1) | AR049577A1 (sv) |
AU (1) | AU2005260143B2 (sv) |
BR (1) | BRPI0512986A (sv) |
CA (1) | CA2569727A1 (sv) |
IL (1) | IL179907A0 (sv) |
MX (1) | MXPA06014663A (sv) |
NO (1) | NO20070570L (sv) |
SA (1) | SA05260190B1 (sv) |
SE (1) | SE0401763D0 (sv) |
TW (1) | TW200605888A (sv) |
UY (1) | UY29003A1 (sv) |
WO (1) | WO2006004533A1 (sv) |
ZA (1) | ZA200610701B (sv) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0100903D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
SE0100902D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
SE0202539D0 (sv) | 2002-08-27 | 2002-08-27 | Astrazeneca Ab | Compounds |
US7648992B2 (en) | 2004-07-05 | 2010-01-19 | Astrazeneca Ab | Hydantoin derivatives for the treatment of obstructive airway diseases |
SE0401762D0 (sv) * | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Novel compounds |
SE0403086D0 (sv) | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Compounds |
SE0403085D0 (sv) | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Novel componds |
MX2007011378A (es) * | 2005-03-16 | 2008-03-18 | Sensus Metering Systems Inc | Metodo, sistema, aparato y producto de programa de computadora para determinar la ubicacion fisica de un sensor. |
TW200740769A (en) * | 2006-03-16 | 2007-11-01 | Astrazeneca Ab | Novel process |
TW200831488A (en) * | 2006-11-29 | 2008-08-01 | Astrazeneca Ab | Novel compounds |
WO2009007747A2 (en) * | 2007-07-11 | 2009-01-15 | Astrazeneca Ab | Hydantoin derivatives used as mmp12 inhibitors |
WO2010090680A1 (en) | 2008-12-15 | 2010-08-12 | Wyeth Llc | Substituted oxindole cb2 agonists |
MX2018000243A (es) * | 2015-07-09 | 2018-03-08 | Mitsubishi Tanabe Pharma Corp | Derivados novedosos de imida y su uso como medicamento. |
IT201700026858A1 (it) * | 2017-03-10 | 2018-09-10 | Univ Degli Studi Padova | Uso di inibitori delle serin proteasi, in particolare di serpinb3 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1708099A (en) * | 1998-06-03 | 1999-12-20 | Amgen, Inc. | N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres |
WO1999065867A1 (en) * | 1998-06-17 | 1999-12-23 | Du Pont Pharmaceuticals Company | Cyclic hydroxamic acids as metalloproteinase inhibitors |
US6340691B1 (en) * | 1999-01-27 | 2002-01-22 | American Cyanamid Company | Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors |
ATE319702T1 (de) * | 1999-08-02 | 2006-03-15 | Verfahren zur herstellung von benzothiophen- derivaten | |
US20020091107A1 (en) * | 2000-09-08 | 2002-07-11 | Madar David J. | Oxazolidinone antibacterial agents |
JP2004527511A (ja) * | 2001-03-15 | 2004-09-09 | アストラゼネカ・アクチエボラーグ | メタロプロテイナーゼ阻害剤 |
SE0100902D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
SE0100903D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
ES2333412T3 (es) * | 2001-05-25 | 2010-02-22 | Bristol-Myers Squibb Company | Derivados de hidantoina como inhibidores de metaloproteinasas de matriz. |
GB0114004D0 (en) * | 2001-06-08 | 2001-08-01 | Glaxo Group Ltd | Chemical compounds |
SE0103710D0 (sv) * | 2001-11-07 | 2001-11-07 | Astrazeneca Ab | Compounds |
SE0202539D0 (sv) * | 2002-08-27 | 2002-08-27 | Astrazeneca Ab | Compounds |
SE0202693D0 (sv) * | 2002-09-11 | 2002-09-11 | Astrazeneca Ab | Compounds |
GB0221246D0 (en) * | 2002-09-13 | 2002-10-23 | Astrazeneca Ab | Compounds |
GB0221250D0 (en) * | 2002-09-13 | 2002-10-23 | Astrazeneca Ab | Compounds |
TWI220073B (en) * | 2003-07-24 | 2004-08-01 | Au Optronics Corp | Method for manufacturing polysilicon film |
SE0401762D0 (sv) * | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Novel compounds |
-
2004
- 2004-07-05 SE SE0401763A patent/SE0401763D0/sv unknown
-
2005
- 2005-06-29 SA SA5260190A patent/SA05260190B1/ar unknown
- 2005-06-29 TW TW094121767A patent/TW200605888A/zh unknown
- 2005-07-04 KR KR1020077000187A patent/KR20070038498A/ko not_active Application Discontinuation
- 2005-07-04 US US11/571,643 patent/US20080004317A1/en not_active Abandoned
- 2005-07-04 WO PCT/SE2005/001093 patent/WO2006004533A1/en active Application Filing
- 2005-07-04 EP EP05755334A patent/EP1794147A1/en not_active Withdrawn
- 2005-07-04 MX MXPA06014663A patent/MXPA06014663A/es not_active Application Discontinuation
- 2005-07-04 BR BRPI0512986-9A patent/BRPI0512986A/pt not_active IP Right Cessation
- 2005-07-04 AU AU2005260143A patent/AU2005260143B2/en not_active Ceased
- 2005-07-04 CN CNA200580022806XA patent/CN1980915A/zh active Pending
- 2005-07-04 JP JP2007520268A patent/JP2008505172A/ja active Pending
- 2005-07-04 CA CA002569727A patent/CA2569727A1/en not_active Abandoned
- 2005-07-05 AR ARP050102792A patent/AR049577A1/es unknown
- 2005-07-05 UY UY29003A patent/UY29003A1/es not_active Application Discontinuation
-
2006
- 2006-12-07 IL IL179907A patent/IL179907A0/en unknown
- 2006-12-19 ZA ZA200610701A patent/ZA200610701B/xx unknown
-
2007
- 2007-01-30 NO NO20070570A patent/NO20070570L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MXPA06014663A (es) | 2007-02-12 |
JP2008505172A (ja) | 2008-02-21 |
EP1794147A1 (en) | 2007-06-13 |
SE0401763D0 (sv) | 2004-07-05 |
CN1980915A (zh) | 2007-06-13 |
ZA200610701B (en) | 2008-08-27 |
US20080004317A1 (en) | 2008-01-03 |
KR20070038498A (ko) | 2007-04-10 |
NO20070570L (no) | 2007-04-10 |
TW200605888A (en) | 2006-02-16 |
IL179907A0 (en) | 2007-05-15 |
UY29003A1 (es) | 2006-02-24 |
AU2005260143A1 (en) | 2006-01-12 |
WO2006004533A1 (en) | 2006-01-12 |
CA2569727A1 (en) | 2006-01-12 |
SA05260190B1 (ar) | 2008-03-26 |
BRPI0512986A (pt) | 2008-04-22 |
AU2005260143B2 (en) | 2009-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR049577A1 (es) | Derivados de hidantoina, procesos para su preparacion, composiciones y su uso | |
AR053554A1 (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos | |
UY29393A1 (es) | Nuevos derivados de amidas, sales farmacéuticas aceptables, composiciones que los contienen, procedimientos de preparación y aplicaciones. | |
AR055076A1 (es) | Derivados de1,1-dioxido de 1,4-benzotiazepina,procedimiento para prepararlos,composiciones farmaceuticas que los contienen y usos en terapeutica. | |
DOP2006000243A (es) | Derivados de pirazina | |
AR063022A1 (es) | Derivados de indol antagonistas del receptor de glucagon, composiciones farmaceuticas que los contienen y usos para tratar diabetes mellitus tipo 2 y estados patologicos relacionados. | |
AR049578A1 (es) | Derivados de hidantoina, procesos de obtencion y composiciones farmaceuticas | |
BRPI0513717A (pt) | derivados de piridina | |
AR051735A1 (es) | Inhibidores pirrolicos de la proteina quinasa erk, sintesis e intermediarios de los mismos. | |
AR049291A1 (es) | Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso | |
ATE431345T1 (de) | Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate | |
PE20020476A1 (es) | Derivados de glucopiranosiloxibencilbenceno y composiciones farmaceuticas que comprenden los mismos | |
AR066882A1 (es) | Derivados de oxadiazol, una composicion farmaceutica que los comprende y su uso en la preparacion de medicamentos para el tratamiento de trastornos asociados con la disfuncion del glutamato. | |
AR051795A1 (es) | Derivados de hidantoina inhibidores de metaloproteinasas | |
AR065806A1 (es) | Derivados de quinolina, procesos para su preparacion, composiciones farmaceuticas que los contienen y usos para el tratamiento de la artritis reumatoidea. | |
BRPI0515081B8 (pt) | composto, processo para a preparação de um sal de guanidino trifluormetilaroil amida, processo para a preparação de um fenil amino pirido pirimidina, composições farmacêuticas e processos para preparar (3,5-bis trifluormetil)-n-[4-metil-3-(4-piridin-3-il-pirimidin-2-ilamino)-fenil]-benzamida | |
AR053569A1 (es) | Derivados de pirazol | |
AR047085A1 (es) | Derivados de (3-oxo-3,4-dihidro-quinoxalina-2-il-amino)benzamida y compuestos relacionados como inhibidores de glucogeno fosforilasa para el tratamiento de diabetes y obesidad | |
UY31046A1 (es) | Derivados sustituidos de n-(3,4-dihidro-2h-cromen-3-il)formamida y n-(1, 2,3 ,4-tetrahidronaftalen-2-il)formamida, sales de los mismos, composiciones que los contienen, procedimientos para su preparacion y aplicaciones | |
AR063988A1 (es) | Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
AR079205A1 (es) | Morfolinotiazoles como moduladores alostericos positivos alfa 7 | |
EA201071019A1 (ru) | Кристаллические формы производных фениламинопиримидина | |
AR056860A1 (es) | Derivados de triazol inhibidores de receptores de quinasa tgf-beta1, composiciones farmaceuticas que los contienen y usos para el tratamiento de tumores | |
AR056014A1 (es) | Compuesto 3-aminocarbazol, composicion farmaceutica que lo contiene y procedimiento para la preparacion del mismo | |
AR073043A1 (es) | Compuestos de azetidinas polisustituidos, composiciones farmaceuticas que los contienen, metodo de preparacion y uso de los mismos en el tratamiento de enfermedades respiratorias, metabolicas y del sistema nervioso central, entre otras. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |